Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy

This study aims to identify baseline medications that, as a proxy for the diseases they are dispensed for, are associated with increased risk of mortality in COVID-19 patients from two regions in Spain and Italy using real-world data. We conducted a cross-country, retrospective, observational study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bliek-Bueno, Kevin, Mucherino, Sara, Poblador-Plou, Beatriz, González-Rubio, Francisca, Aza-Pascual-Salcedo, Mercedes, Orlando, Valentina, Clerencia-Sierra, Mercedes, Ioakeim-Skoufa, Ignatios, Coscioni, Enrico, Carmona-Pírez, Jonás, Perrella, Alessandro, Trama, Ugo, Prados-Torres, Alexandra, Menditto, Enrica, Gimeno-Miguel, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623536/
https://www.ncbi.nlm.nih.gov/pubmed/34831541
http://dx.doi.org/10.3390/ijerph182211786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623536/
https://www.ncbi.nlm.nih.gov/pubmed/34831541
http://dx.doi.org/10.3390/ijerph182211786

Ejemplares similares